Market Research Logo

Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country. 2019 to 2023

Global Clinical In Vitro Diagnostic Medical Laboratory Services Market. Strategies & Trends. Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Molecular Diagnostic and Esoteric by Country. 2019 to 2023

Report Overview:

A market that just keeps on growing. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. Learn all about it in this new report from Howe Sound Research. A range of dynamic trends are pushing market growth and company valuations. Trends like ......

  • the genetic blizzard
  • emerging economies and global prosperity
  • pharmacogenomics
  • healthcare expansion in China
  • climate change
  • globalization
  • automation
Exciting technical developments especially in the area of molecular diagnostics and pharmacogenomics hold the promise of a dynamic, growing and evolving world market that is moving out of the national and regional orientation and onto a global stage.

The report provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2018 United States Medicare Fee Payment Schedules to help sharpen your pricing. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions.

Order an Enterprise Version specifically customized for your organizations needs for distribution throughout your company.

Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges. Questions? Email us at service at howesoundresearch.com. We would be glad to let you know if we can be of help.

The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.


1. Introduction and Market Definition
1.1 The Growing Demand for Clinical Testing
1.2 Defining the Opportunity
1.2.1 Volumes
1.2.2 Prices
1.2.3 Revenue Market Size
1.3 Methods and Sources
1.3.1 Authors
1.3.2 Sources
1.4 U.S. Medical Market and Clinical Laboratory Testing - Perspective
1.3.1 U.S. Medicare Expenditures for Clinical Testing
2. Overview of a Dynamic Market
2.1 Market Players – Roles & Impacts
2.1.1 Supplier/pharmaceutical
2.1.2 Independent lab specialized/esoteric
2.1.3 Independent lab national/regional
2.1.4 Independent lab analytical
2.1.5 Public National/regional lab
2.1.6 Hospital lab
2.1.7 Physician lab
2.1.8 Audit body
2.2 Segmentation – Different Approaches
2.2.1 Traditional Market Segmentation
2.2.2 Laboratory Focus and Segmentation
2.3 Structure of Clinical Testing Industry
2.3.1 The Hospital Lab – Share of the Pie
2.3.2 Key Role for Economies of Scale
2.3.3 Physician Office Lab’s are Still Here
2.3.4 Physician’s and POCT – Reviving Patient Service in China
2.4 Profiles of Key Companies
2.4.1 Quest Diagnostics
2.4.2 Laboratory Corporation of America
2.4.3 Lifelabs Medical Laboratory Services
2.4.4 ACM Medical Laboratory
2.4.5 Spectra Laboratories, Inc.
2.4.6 Bio-Reference Laboratories, Inc.
2.4.7 CompuNet Clinical Laboratories, LLC
2.4.8 Genzyme Corporation
2.4.9 Sonic Healthcare Limited
2.4.10 Exagen Diagnostics, Inc.
2.4.11 Clongen Laboratories LLC
2.4.12 Clinical Reference Laboratory, Inc.
2.4.13 Mid America Clinical Laboratories, LLC
2.4.14 Miraca Life Sciences, Inc
2.4.15 Psychemedics Corp
2.4.16 Aurora Diagnostics, LLC
2.4.17 DL Reference Laboratory
2.4.18 Myriad Genetics, Inc.
2.4.19 Bioscientia Institut fuer Medizinische Diagnostik GmbH
2.4.20 Acibadem Labmed Laboratory
2.4.21 Eurofins Scientific
2.4.22 The Doctor’s Laboratory (Sonic Healthcare U.K.)
2.4.23 Pathology Inc.
2.4.24 Gribbles Pathology
2.4.25 B.P. CLINICAL LAB
2.4.26 Diagnósticos da América (DASA)
2.4.27 American Bio-Clinical Laboratories, Int'l
2.4.28 Adicon Clinical Laboratories
2.4.29 Dian Diagnostics
2.4.30 Kingmed Diagnostics
2.4.31 Ascend Clinical, LLC
2.4.32 Unilabs SA
2.4.33 American Pathology Partners, Inc.
2.4.34 Integrated Regional Laboratories, Inc.
2.4.35 Viracor Laboratories
2.4.36 Neogenomics
2.4.37 Genomic Health, Inc.
2.4.38 ARUP Laboratories, Inc.
2.4.39 Enzo Biochem, Inc.
2.4.40 Mayo Medical Laboratories.
2.5 National and Regional Diversity
3. Trends Driving a Changing Market
3.1 Growth Is Pushed from Many Sides
3.1.1 Understanding the Impact of Aging Population.
3.1.2 Economic growth a Key Driver.
3.1.3 Point of Care Testing can increase demand
3.1.4 Alternative Medicine Creates Testing Opportunity
3.1.5 Esoteric Testing Moving Mainstream
3.1.6 Genetic Based Testing Creates New Department and New Discipline
3.2 Factors at Work To Shrink The Market
3.2.1 Lower costs trend to continue
3.2.2 Economic or population contraction.
3.2.3 Testing usage analysis curtailing growth.
3.2.4 Wellness has a downside
3.2.5 Test Displacement Impacts Important
3.2.6 Point of Care Testing
3.3 Automation
3.3.1 Stranded LIMS Investment
3.3.2 Software as a Service
3.3.3 Physician Office and Access Systems
3.4 Environment and Evolution
3.5 Diagnostic Technology Development
3.5.1 Next Generation Sequencing Fuels a Revolution.
3.5.2 Impact of NGS on pricing
3.5.3 POCT/Self Testing Disruptive Force
3.5.4 Pharmacogenomics Blurs Diagnosis and Treatment
3.5.5 CGES Testing, A Brave New World
3.5.6 Molecular Diagnostics Technologies at The Forefront of Growth
3.5.7 Biochips/Giant magneto resistance based assay
4. Laboratory, Molecular Diagnostics and Genomic Testing Recent Developments
4.1 Recent Developments – Importance and How to Use This Section
4.1.1 Importance of These Developments
4.1.2 How to Use This Section
4.2 GROUPE BIO7 to be Sold to CERBA HEALTHCARE
4.3 GE Healthcare and Roche Partner to Develop Digital Diagnostics Platform
4.4 Digipath Enters into Letter of Intent to Acquire Clinical Lab Companies
4.5 PSP to acquire European medical lab services company
4.6 Mars, Incorporated to Acquire VCA Inc.
4.7 Caprion Biosciences Acquires the Immune Monitoring Laboratory from ImmuneHealth
4.8 Takara Bio USA Holdings and Rubicon Genomics Announce Merger Agreement
4.9 Instrumentation Laboratory Acquires CA Casyso AG
4.10 Schryver Medical Completes Acquisitions of Professional Clinical Laboratory, Inc.
4.11 Grifols acquires Hologic’s blood screening unit for $1.85bn
4.12 Bio-Rad Laboratories to buy US firm RainDance Technologies
4.13 Abbott Laboratories to buy St. Jude Medical for $25 billion
4.14 CombiMatrix Gets Serious About Potential M&A Options in Wake of $8M Offering
4.15 Abbott to Acquire Alere, Becoming Leader in Point of Care Testing
4.16 Achieving Dx Ambitions Key to Avant-Amarantus-Theranostics Merger
4.17 LabCorp Agrees to Acquire Assets of Pathology Inc.
4.18 NeoGenomics Completes Acquisition of Clarient, Inc.
4.19 FDA Gets Pushback on Move to Regulate Lab Developed Tests
4.20 Cancer Genetics, Inc. Announces Partnership
4.21 Theranos plans to close all its clinical labs
4.22 Forte Capital Lowers stake in Laboratory Corp.
4.23 US Oncology Network Selects Myriad Genetics
4.24 Pyxant Labs Commences Clinical Laboratory Testing Services
4.25 Viewics Launches Diabetes Management
4.26 Alpha Genomix And Rx30 Partner
4.27 LabCorp Doubles Testing Capacity Of Covance
4.28 LabCorp to acquire clinical laboratories from Mount Sinai
4.29 PerkinElmer to buy Germany's Euroimmun for about $1.3 billion
4.30 LabCorp to Acquire Chiltern for Approximately $1.2 Billion in Cash
4.31 Precipio Diagnostics and Transgenomic Complete Merger
4.32 $550 Dock Turns a Smartphone into a Medical Lab
4.33 LabCorp & Interpace Extend Deal, Boost Cancer Portfolio
4.34 Charles River Labs to acquire contract research firm for $800M
4.35 Quest Diagnostics to Acquire Shiel Medical Laboratory from Fresenius Medical Care
4.36 Quest Diagnostics to Acquire MedXM
4.37 Overview of Clinical Diagnostic Acquisition Activity
4.38 New Sysmex Device Provides Blood Test Results at Point of Care in Minutes
4.39 FDA, Congress Return Attention to Direct-to-Consumer Genetic Testing
4.40 QIAGEN Enters into Agreement to Acquire STAT-Dx
4.41 Quest Diagnostics Acquires Laboratory Services Operation in Central Michigan
4.42 NeoGenomics to acquire Genoptix, Inc.
4.43 Quest Diagnostics to Acquire U.S. Laboratory Services Business of Oxford Immunotec
5. Country Market Sizes – North America 2015 to 2023
5.1 United States of America 2015 to 2023
5.1.1 Clinical Chemistry – Volumes, Prices, Revenues
5.1.2 Microbiology – Volumes, Prices, Revenues
5.1.3 Hematology – Volumes, Prices, Revenues
5.1.4 Anatomic Pathology – Volumes, Prices, Revenues
5.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
5.1.6 All Clinical Testing – Volumes, Prices, Revenues
5.1.7 Esoteric – Volumes, Prices, Revenues
5.2 Canada 2015 to 2023
5.2.1 Clinical Chemistry – Volumes, Prices, Revenues
5.2.2 Microbiology – Volumes, Prices, Revenues
5.2.3 Hematology – Volumes, Prices, Revenues
5.2.4 Anatomic Pathology – Volumes, Prices, Revenues
5.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
5.2.6 All Clinical Testing – Volumes, Prices, Revenues
5.2.7 Esoteric – Volumes, Prices, Revenues
6. Country Markets – Europe 2015 to 2023
6.1 France 2015 to 2023
6.1.1 Clinical Chemistry – Volumes, Prices, Revenues
6.1.2 Microbiology – Volumes, Prices, Revenues
6.1.3 Hematology – Volumes, Prices, Revenues
6.1.4 Anatomic Pathology – Volumes, Prices, Revenues
6.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.1.6 All Clinical Testing – Volumes, Prices, Revenues
6.1.7 Esoteric – Volumes, Prices, Revenues
6.2 Germany 2015 to 2023
6.2.1 Clinical Chemistry – Volumes, Prices, Revenues
6.2.2 Microbiology – Volumes, Prices, Revenues
6.2.3 Hematology – Volumes, Prices, Revenues
6.2.4 Anatomic Pathology – Volumes, Prices, Revenues
6.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.2.6 All Clinical Testing – Volumes, Prices, Revenues
6.2.7 Esoteric – Volumes, Prices, Revenues
6.3 United Kingdom 2015 to 2023
6.3.1 Clinical Chemistry – Volumes, Prices, Revenues
6.3.2 Microbiology – Volumes, Prices, Revenues
6.3.3 Hematology – Volumes, Prices, Revenues
6.3.4 Anatomic Pathology – Volumes, Prices, Revenues
6.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.3.6 All Clinical Testing – Volumes, Prices, Revenues
6.3.7 Esoteric – Volumes, Prices, Revenues
6.4 Spain 2015 to 2023
6.4.1 Clinical Chemistry – Volumes, Prices, Revenues
6.4.2 Microbiology – Volumes, Prices, Revenues
6.4.3 Hematology – Volumes, Prices, Revenues
6.4.4 Anatomic Pathology – Volumes, Prices, Revenues
6.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.4.6 All Clinical Testing – Volumes, Prices, Revenues
6.4.7 Esoteric – Volumes, Prices, Revenues
6.5 Italy 2015 to 2023
6.5.1 Clinical Chemistry – Volumes, Prices, Revenues
6.5.2 Microbiology – Volumes, Prices, Revenues
6.5.3 Hematology – Volumes, Prices, Revenues
6.5.4 Anatomic Pathology – Volumes, Prices, Revenues
6.5.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.5.6 All Clinical Testing – Volumes, Prices, Revenues
6.5.7 Esoteric – Volumes, Prices, Revenues
6.6 Russia 2015 to 2023
6.6.1 Clinical Chemistry – Volumes, Prices, Revenues
6.6.2 Microbiology – Volumes, Prices, Revenues
6.6.3 Hematology – Volumes, Prices, Revenues
6.6.4 Anatomic Pathology – Volumes, Prices, Revenues
6.6.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.6.6 All Clinical Testing – Volumes, Prices, Revenues
6.6.7 Esoteric – Volumes, Prices, Revenues
6.7 Remainder of Europe and Former Soviet Union 2015 to 2023
6.7.1 Clinical Chemistry – Volumes, Prices, Revenues
6.7.2 Microbiology – Volumes, Prices, Revenues
6.7.3 Hematology – Volumes, Prices, Revenues
6.7.4 Anatomic Pathology – Volumes, Prices, Revenues
6.7.5 Molecular Diagnostics – Volumes, Prices, Revenues
6.7.6 All Clinical Testing – Volumes, Prices, Revenues
6.7.7 Esoteric – Volumes, Prices, Revenues
7. Country Markets – Asia Pacific 2015 to 2023
7.1 China 2015 to 2023
7.1.1 Clinical Chemistry – Volumes, Prices, Revenues
7.1.2 Microbiology – Volumes, Prices, Revenues
7.1.3 Hematology – Volumes, Prices, Revenues
7.1.4 Anatomic Pathology – Volumes, Prices, Revenues
7.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.1.6 All Clinical Testing – Volumes, Prices, Revenues
7.1.7 Esoteric – Volumes, Prices, Revenues
7.2 Japan 2015 to 2023
7.2.1 Clinical Chemistry – Volumes, Prices, Revenues
7.2.2 Microbiology – Volumes, Prices, Revenues
7.2.3 Hematology – Volumes, Prices, Revenues
7.2.4 Anatomic Pathology – Volumes, Prices, Revenues
7.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.2.6 All Clinical Testing – Volumes, Prices, Revenues
7.2.7 Esoteric – Volumes, Prices, Revenues
7.3 South Korea 2015 to 2023
7.3.1 Clinical Chemistry – Volumes, Prices, Revenues
7.3.2 Microbiology – Volumes, Prices, Revenues
7.3.3 Hematology – Volumes, Prices, Revenues
7.3.4 Anatomic Pathology – Volumes, Prices, Revenues
7.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.3.6 All Clinical Testing – Volumes, Prices, Revenues
7.3.7 Esoteric – Volumes, Prices, Revenues
7.4 India 2015 to 2023
7.4.1 Clinical Chemistry – Volumes, Prices, Revenues
7.4.2 Microbiology – Volumes, Prices, Revenues
7.4.3 Hematology – Volumes, Prices, Revenues
7.4.4 Anatomic Pathology – Volumes, Prices, Revenues
7.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.14.6 All Clinical Testing – Volumes, Prices, Revenues
7.4.7 Esoteric – Volumes, Prices, Revenues
7.5 Australia 2015 to 2023
7.5.1 Clinical Chemistry – Volumes, Prices, Revenues
7.5.2 Microbiology – Volumes, Prices, Revenues
7.5.3 Hematology – Volumes, Prices, Revenues
7.5.4 Anatomic Pathology – Volumes, Prices, Revenues
7.5.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.5.6 All Clinical Testing – Volumes, Prices, Revenues
7.5.7 Esoteric – Volumes, Prices, Revenues
7.6 Rest of Asia Pacific 2015 to 2023
7.6.1 Clinical Chemistry – Volumes, Prices, Revenues
7.6.2 Microbiology – Volumes, Prices, Revenues
7.6.3 Hematology – Volumes, Prices, Revenues
7.6.4 Anatomic Pathology – Volumes, Prices, Revenues
7.6.5 Molecular Diagnostics – Volumes, Prices, Revenues
7.6.6 All Clinical Testing – Volumes, Prices, Revenues
7.6.7 Esoteric – Volumes, Prices, Revenues
8. Country Markets – Latin America, Africa & The Middle East 2015 to 2023
8.1 Brazil 2015 to 2023
8.1.1 Clinical Chemistry – Volumes, Prices, Revenues
8.1.2 Microbiology – Volumes, Prices, Revenues
8.1.3 Hematology – Volumes, Prices, Revenues
8.1.4 Anatomic Pathology – Volumes, Prices, Revenues
8.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.1.6 All Clinical Testing – Volumes, Prices, Revenues
8.1.7 Esoteric – Volumes, Prices, Revenues
8.2 Mexico 2015 to 2023
8.2.1 Clinical Chemistry – Volumes, Prices, Revenues
8.2.2 Microbiology – Volumes, Prices, Revenues
8.2.3 Hematology – Volumes, Prices, Revenues
8.2.4 Anatomic Pathology – Volumes, Prices, Revenues
8.2.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.2.6 All Clinical Testing – Volumes, Prices, Revenues
8.2.7 Esoteric – Volumes, Prices, Revenues
8.3 Remainder of Latin America 2015 to 2023
8.3.1 Clinical Chemistry – Volumes, Prices, Revenues
8.3.2 Microbiology – Volumes, Prices, Revenues
8.3.3 Hematology – Volumes, Prices, Revenues
8.3.4 Anatomic Pathology – Volumes, Prices, Revenues
8.3.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.3.6 All Clinical Testing – Volumes, Prices, Revenues
8.3.7 Esoteric – Volumes, Prices, Revenues
8.4 Africa & The Middle East 2015 to 2023
8.4.1 Clinical Chemistry – Volumes, Prices, Revenues
8.4.2 Microbiology – Volumes, Prices, Revenues
8.4.3 Hematology – Volumes, Prices, Revenues
8.4.4 Anatomic Pathology – Volumes, Prices, Revenues
8.4.5 Molecular Diagnostics – Volumes, Prices, Revenues
8.4.6 All Clinical Testing – Volumes, Prices, Revenues
8.4.7 Esoteric – Volumes, Prices, Revenues
9. Global Market Summary 2015 to 2023
9.1 Global Market 2015 to 2023
9.1.1 Clinical Chemistry – Volumes, Prices, Revenues
9.1.2 Microbiology – Volumes, Prices, Revenues
9.1.3 Hematology – Volumes, Prices, Revenues
9.1.4 Anatomic Pathology – Volumes, Prices, Revenues
9.1.5 Molecular Diagnostics – Volumes, Prices, Revenues
9.1.6 All Clinical Testing – Volumes, Prices, Revenues
9.1.7 Esoteric – Volumes, Prices, Revenues
10. The Future of the Clinical Laboratory
Appendices
I. United States Medicare System: January 2018 Clinical Laboratory Fees Schedule – National Limit and
Midpoint
Table of Tables
Table 1 Medicare Clinical Lab Expenditures Actual & Forecast 2004 to 2021 ($Billion)
Table 2 Market Players by Type
Table 3 Clinical Laboratory Departments and Segments
Table 4 Laboratory Management Focus – Different Approaches
Table 5 Key Segmentation Variables Going Forward
Table 6 Factors Affecting Local Clinical Testing Demand
Table 7 Seven Factors Driving Growth
Table 8 Alternative Medicine Creates New Clinical Testing Markets
Table 9 Six Factors Limiting Growth
Table 10 Key Diagnostic Laboratory Technology Trends
Table 11 Next Generation Sequencing Technologies – Speed and Cost
Table 12 Key Point of Care Testing Uses
Table 13 Clinical Application Areas for Molecular Diagnostics
Table 14 Clinical Chemistry - Volume Price and Revenue Forecast
Table 15 Microbiology - Volume Price and Revenue Forecast
Table 16 Hematology - Volume Price and Revenue Forecast
Table 17 Anatomic Pathology - Volume Price and Revenue Forecast
Table 18 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 19 All Clinical Testing - Volume Price and Revenue Forecast
Table 20 Esoteric - Volume Price and Revenue Forecast
Table 21 Clinical Chemistry - Volume Price and Revenue Forecast
Table 22 Microbiology - Volume Price and Revenue Forecast
Table 23 Hematology - Volume Price and Revenue Forecast
Table 24 Anatomic Pathology - Volume Price and Revenue Forecast
Table 25 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 26 All Clinical Testing - Volume Price and Revenue Forecast
Table 27 Esoteric - Volume Price and Revenue Forecast
Table 28 Clinical Chemistry - Volume Price and Revenue Forecast
Table 29 Microbiology - Volume Price and Revenue Forecast
Table 30 Hematology - Volume Price and Revenue Forecast
Table 31 Anatomic Pathology - Volume Price and Revenue Forecast
Table 32 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 33 All Clinical Testing - Volume Price and Revenue Forecast
Table 34 Esoteric - Volume Price and Revenue Forecast
Table 35 Clinical Chemistry - Volume Price and Revenue Forecast
Table 36 Microbiology - Volume Price and Revenue Forecast
Table 37 Hematology - Volume Price and Revenue Forecast
Table 38 Anatomic Pathology - Volume Price and Revenue Forecast
Table 39 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 40 All Clinical Testing - Volume Price and Revenue Forecast
Table 41 Esoteric - Volume Price and Revenue Forecast
Table 42 Clinical Chemistry - Volume Price and Revenue Forecast
Table 43 Microbiology - Volume Price and Revenue Forecast
Table 44 Hematology - Volume Price and Revenue Forecast
Table 45 Anatomic Pathology - Volume Price and Revenue Forecast
Table 46 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 47 All Clinical Testing - Volume Price and Revenue Forecast
Table 48 Esoteric - Volume Price and Revenue Forecast
Table 49 Clinical Chemistry - Volume Price and Revenue Forecast
Table 50 Microbiology - Volume Price and Revenue Forecast
Table 51 Hematology - Volume Price and Revenue Forecast
Table 52 Anatomic Pathology - Volume Price and Revenue Forecast
Table 53 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 54 All Clinical Testing - Volume Price and Revenue Forecast
Table 55 Esoteric - Volume Price and Revenue Forecast
Table 56 Clinical Chemistry - Volume Price and Revenue Forecast
Table 57 Microbiology - Volume Price and Revenue Forecast
Table 58 Hematology - Volume Price and Revenue Forecast
Table 59 Anatomic Pathology - Volume Price and Revenue Forecast
Table 60 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 61 All Clinical Testing - Volume Price and Revenue Forecast
Table 62 Esoteric - Volume Price and Revenue Forecast
Table 63 Clinical Chemistry - Volume Price and Revenue Forecast
Table 64 Microbiology - Volume Price and Revenue Forecast
Table 65 Hematology - Volume Price and Revenue Forecast
Table 66 Anatomic Pathology - Volume Price and Revenue Forecast
Table 67 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 68 All Clinical Testing - Volume Price and Revenue Forecast
Table 69 Esoteric - Volume Price and Revenue Forecast
Table 70 Clinical Chemistry - Volume Price and Revenue Forecast
Table 71 Microbiology - Volume Price and Revenue Forecast
Table 72 Hematology - Volume Price and Revenue Forecast
Table 73 Anatomic Pathology - Volume Price and Revenue Forecast
Table 74 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 75 All Clinical Testing - Volume Price and Revenue Forecast
Table 76 Esoteric - Volume Price and Revenue Forecast
Table 77 Clinical Chemistry - Volume Price and Revenue Forecast
Table 78 Microbiology - Volume Price and Revenue Forecast
Table 79 Hematology - Volume Price and Revenue Forecast
Table 80 Anatomic Pathology - Volume Price and Revenue Forecast
Table 81 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 82 All Clinical Testing - Volume Price and Revenue Forecast
Table 83 Esoteric - Volume Price and Revenue Forecast
Table 84 Clinical Chemistry - Volume Price and Revenue Forecast
Table 85 Microbiology - Volume Price and Revenue Forecast
Table 86 Hematology - Volume Price and Revenue Forecast
Table 87 Anatomic Pathology - Volume Price and Revenue Forecast
Table 88 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 89 All Clinical Testing - Volume Price and Revenue Forecast
Table 90 Esoteric - Volume Price and Revenue Forecast
Table 91 Clinical Chemistry - Volume Price and Revenue Forecast
Table 92 Microbiology - Volume Price and Revenue Forecast
Table 93 Hematology - Volume Price and Revenue Forecast
Table 94 Anatomic Pathology - Volume Price and Revenue Forecast
Table 95 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 96 All Clinical Testing - Volume Price and Revenue Forecast
Table 97 Esoteric - Volume Price and Revenue Forecast
Table 98 Clinical Chemistry - Volume Price and Revenue Forecast
Table 99 Microbiology - Volume Price and Revenue Forecast
Table 100 Hematology - Volume Price and Revenue Forecast
Table 101 Anatomic Pathology - Volume Price and Revenue Forecast
Table 102 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 103 All Clinical Testing - Volume Price and Revenue Forecast
Table 104 Esoteric - Volume Price and Revenue Forecast
Table 105 Clinical Chemistry - Volume Price and Revenue Forecast
Table 106 Microbiology - Volume Price and Revenue Forecast
Table 107 Hematology - Volume Price and Revenue Forecast
Table 108 Anatomic Pathology - Volume Price and Revenue Forecast
Table 109 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 110 All Clinical Testing - Volume Price and Revenue Forecast
Table 111 Esoteric - Volume Price and Revenue Forecast
Table 112 Clinical Chemistry - Volume Price and Revenue Forecast
Table 113 Microbiology - Volume Price and Revenue Forecast
Table 114 Hematology - Volume Price and Revenue Forecast
Table 115 Anatomic Pathology - Volume Price and Revenue Forecast
Table 116 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 117 All Clinical Testing - Volume Price and Revenue Forecast
Table 118 Esoteric - Volume Price and Revenue Forecast
Table 119 Clinical Chemistry - Volume Price and Revenue Forecast
Table 120 Microbiology - Volume Price and Revenue Forecast
Table 121 Hematology - Volume Price and Revenue Forecast
Table 122 Anatomic Pathology - Volume Price and Revenue Forecast
Table 123 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 124 All Clinical Testing - Volume Price and Revenue Forecast
Table 125 Esoteric - Volume Price and Revenue Forecast
Table 126 Clinical Chemistry - Volume Price and Revenue Forecast
Table 127 Microbiology - Volume Price and Revenue Forecast
Table 128 Hematology - Volume Price and Revenue Forecast
Table 129 Anatomic Pathology - Volume Price and Revenue Forecast
Table 130 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 131 All Clinical Testing - Volume Price and Revenue Forecast
Table 132 Esoteric - Volume Price and Revenue Forecast
Table 133 Clinical Chemistry - Volume Price and Revenue Forecast
Table 134 Microbiology - Volume Price and Revenue Forecast
Table 135 Hematology - Volume Price and Revenue Forecast
Table 136 Anatomic Pathology - Volume Price and Revenue Forecast
Table 137 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 138 All Clinical Testing - Volume Price and Revenue Forecast
Table 139 Esoteric - Volume Price and Revenue Forecast
Table 140 Clinical Chemistry - Volume Price and Revenue Forecast
Table 141 Microbiology - Volume Price and Revenue Forecast
Table 142 Hematology - Volume Price and Revenue Forecast
Table 143 Anatomic Pathology - Volume Price and Revenue Forecast
Table 144 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 145 All Clinical Testing - Volume Price and Revenue Forecast
Table 146 Esoteric - Volume Price and Revenue Forecast
Table 147 Clinical Chemistry - Volume Price and Revenue Forecast
Table 148 Microbiology - Volume Price and Revenue Forecast
Table 149 Hematology - Volume Price and Revenue Forecast
Table 150 Anatomic Pathology - Volume Price and Revenue Forecast
Table 151 Molecular Diagnostics - Volume Price and Revenue Forecast
Table 152 All Clinical Testing - Volume Price and Revenue Forecast
Table 153 Esoteric - Volume Price and Revenue Forecast
Table 154 2018 Clinical Lab Fee Schedule
Table of Figures
Figure 1 Medicare Clinical Lab Expenditures 2004 to 2021 ($Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report